Kadmon is a New York-based biopharmaceutical company that discovers, develops and commercializes drugs for the treatment of cancer and immunology disorders.
Business Model:
Revenue: $8.3M
Employees: 51-200
Address: 450 East 29th Street
City: New York
State: NY
Zip: 10016
Country: US
Kadmon is a New York-based biopharmaceutical company that discovers, develops and commercializes drugs for the treatment of cancer and immunology disorders.
Contact Phone:
+18339005366
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/28/2016
IPO Valuation:
$651M
Ticker Symbol:
KDMN
IPO Price:
$12/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Post-IPO Equity | $23M | 7/2010 | Venture Round | $10.8M | 2/2021 | Post-IPO Debt | $240M | 6/2020 | Post-IPO Equity | $50M | 7/2016 | IPO | $75M | 8/2014 | Venture Round | $5.7M | 8/2012 | Venture Round | $4.7M | 11/2019 | Post-IPO Equity | $101.6M | 6/2018 | Post-IPO Equity | $113.2M | 4/2020 | Debt | $3.1M | 7/2014 | Equity | $5.7M | 9/2017 | Post-IPO Equity | 3 | $80.4M |
RA Capital Management Vivo Capital Acuta Capital Partners RA Capital Management Vivo Capital Acuta Capital Partners |
11/2015 | Equity | $10M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|